Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 2.75M | 3.03M | 2.97M | 3.24M | 3.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.75M | 3.03M | 2.97M | 3.24M | 3.30M |
| Cost of Revenue | 1.49M | 1.62M | 1.56M | 1.71M | 2.51M |
| Gross Profit | 1.27M | 1.42M | 1.41M | 1.53M | 797.00K |
| SG&A Expenses | 1.11M | 1.20M | 1.30M | 1.55M | 1.84M |
| Depreciation & Amortization | 16.00K | 17.00K | 23.00K | 23.00K | 28.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.91M | 3.17M | 3.21M | 3.63M | 4.78M |
| Operating Income | -153.00K | -134.00K | -241.00K | -387.00K | -1.48M |
| Income Before Tax | -349.00K | -353.00K | -432.00K | -3.59M | -1.65M |
| Income Tax Expenses | -- | 4.00K | 5.00K | -62.00K | 18.00K |
| Earnings from Continuing Operations | -349.00K | -357.00K | -437.00K | -3.53M | -1.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -349.00K | -357.00K | -437.00K | -3.53M | -1.66M |
| EBIT | -153.00K | -134.00K | -241.00K | -387.00K | -1.48M |
| EBITDA | -42.00K | -18.00K | -107.00K | -247.00K | -1.33M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.17 | -0.08 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.17 | -0.08 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 |
| Average Basic Shares Outstanding | 21.84M | 21.78M | 21.49M | 21.30M | 21.33M |
| Average Diluted Shares Outstanding | 21.84M | 21.78M | 21.49M | 21.30M | 21.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
